CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma

American Journal of Clinical Pathology

Volumn 109, Issue 3, 1998, Pages 309-314

  Ingle, Rajendrakumar ^a   Jennings, Timothy A ^a   Goodman, Max L ^b   Pilch, Ben Z ^b   Bergman, Simon ^b   Ross, Jeffrey S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CD44; Sinonasal inverted papilloma; Squamous cell carcinoma; Tumor invasion

Indexed keywords

HERMES ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA;

EID: 0031888864     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.3.309     Document Type: Article

References (39)

1. Cummings CW, Goodman ML. Inverted papillomas of the nose and paranasal sinuses. Arch Otolaryngol. 1970;92:445-449.
2. Snyder RN, Perzin KH. Papillomatosis of nasal cavity and paranasal sinuses (inverted papilloma, squamous papilloma): a clinicopathologic study. Cancer. 1972;30:668-690.
3. Ridolfi RL, Lieberman PH, Erlandson RA, et al. Schneiderian papillomas: a clinicopathologic study of 30 cases. Am J Surg Pathol. 1997;1:43-53.
4. Christenson WN, Smith RRL. Schneiderian papillomas: a clinicopathologic study of 67 cases. Hum Pathol. 1986;17:393-100.
5. Michaels L, Young M. Histogenesis of papillomas of the nose and paranasal sinuses. Arch Pathol Lab Med. 1995;119:821-826.
6. Michaels L. Benign mucosal tumors of the nose and paranasal sinuses. Semin Diagn Pathol. 1996;13:113-117.
7. Henrickson NG. Papillomas of the nose: a clinical survey and contribution to our knowledge of these tumors. Acta Otolaryngol (Stockh). 1952;42:18-29.
8. Woodson GE, Robbins KT, Michaels L. Inverted papilloma: considerations in treatment. Arch Otolaryngol 1985;111:806-811.
9. Phillips PP, Gustafson RO, Facer GW. The clinical behavior of inverting papilloma of the nose and paranasal sinuses: report of 112 cases and review of the literature. Laryngoscope. 1990;100:463-469.
10. Bielamowicz S, Calcaterra TZ, Watson D. Inverting papilloma of the head and neck: UCLA update. Otolaryngol Head Neck Surg. 1993;109:71-76.
11. Haynes BF, Liao HX, Patton KL. The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells. 1991;3:347-350.
12. Underbill C. CD44: The hyaluronan receptor. J Cell Sci. 1992;103:293-298.
13. Screaton GR, Bell MV, Jackson DG, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89:12160-12164.
14. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271-335.
15. Jalkanen S, Bargatze RF, Herron LR, et al. A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol. 1986;16:1195-1202.
16. Matsumura Y, Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 1992;340:1053-1058.
17. Heider KH, Hofman M, Hors E, et al. A human homologue of the rat metastasis associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol. 1992;120:623-627.
18. Heider KH, Dammrich J, Angel SP, et al. Differential expression of CD44 splice variants in intestinal and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res. 1993;53:4197-4203.
19. Kallakury BVS, Yang F, Figge J, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma correlation with tumor grade and ploidy. Cancer. 1996;78:1461-1469.
20. Washimi O, Ueda R, Ariyoshi Y, et al. Expression of CD44 variant isoforms in normal and neoplastic cells of the lung. Jpn J Cancer Res. 1994;85:1112-1116.
21. Dali P, Heider KH, Hekele A, et al. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res. 1994;54:3337-3341.
22. Jalkanen S, Joensuu H, Soderstrom KO, et al. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J Clin Invest. 1991;87:1835-1840.
23. Kuppner MC, Meir EV, Gauthier T, et al. Differential expression of the CD44 molecule in human brain tumors. Int J Cancer. 1992;50:572-577.
24. Sugino T, Gorham H, Yoshida K, et al. Progressive loss of CD44 gene expression in invasive bladder cancer. Am J Pathol. 1996;149:873-882.
25. Fujita N, Yaegashi N, Ide Y, et al. Expression of CD44 in normal human versus tumor endometrial tissue: possible implication of reduced expression of CD44 in lymph-vascular involvement of cancer cells. Cancer Res. 1994;54:3922-3928.
26. Cannistra SA, Abu-Jawdeh G, Niloff J, et al. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J Clin Oncol. 1995;13:1912-1921.
27. Joensuu H, Clemi PJ, Toikkanen S, et al. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol. 1993;143:867-874.
28. Ross JS, del Rosario AD, Bui HX, et al. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma. Mod Pathol. 1996;9:854-860.
29. Ross JS, del Rosario AD, Sanderson B, et al. Selective expression of CD44 cell adhesion molecule in thyroid papillary carcinoma fine-needle aspirates. Diagn Cytopathol. 1996;14:287-291.
30. Ermak G, Jennings T, Robinson L, et al. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Cancer Res. 1996;56:1037-1042.
31. Salmi M, Gron-Virta K, Sointu P, et al. Regulated expression of exon V6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol. 1993;122:431-442.
32. Herold-Mende C, Seiter S, Born AI, et al. Expression of CD44 splice variants in squamous epithelium and squamous cell carcinoma of the head and neck. J Pathol. 1996;179:66-73.
33. Kunishi M, Kayada Y, Tsumura M, et al. Expression of CD44 variants 6 and its metastatic potential in squamous cell carcinoma of the oral cavity. Gan To Kagaku Ryoho. 1996;23:1045-1048.
34. Spafford MF, Koeppe J, Pan Z, et al. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1996;122:627-632.
35. Macdonald MR, Le KT, Freeman J, et al. A majority of inverted sinonasal papillomas carries Epstein-Barr virus genomes. Cancer. 1995;75:2307-2312.
36. Gaffey MJ, Frierson HF, Weiss LM, et al. Human papilloma virus in Epstein-Barr virus in sinonasal Schneiderian papillomas. Am J Clin Pathol. 1996;106:475-482.
37. Caruana SM, Eberle RC, McCormick SA, et al. p53 alteration and human papilloma virus infection in paranasal sinus cancer. Cancer. 1997;79:1320-1328.
38. Shtivelman E, Bishop JM. Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol. 1991;11:5446-5453.
39. Figge J, del Rosario, Gerasimov G, et al. Preferential expression of cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol. 1994;61:203-211.